G1 Therapeutics

COSELA

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

G1 Therapeutics

Cosela HCPCS:

J1448

HCPCS Code Descriptor:

Injection, trilaciclib, 1mg

Category:

J Code

Cosela NDCs:

73462-0101-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Cosela CPT Codes:

-96365 - Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Cosela:

COSELA is an Oncology drug manufactured by G1 Therapeutics and administered via the Intravenous route of administration. The J Code: J1448 is aligned to the drug COSELA.

ACCESS PRICING AND MORE BY REGISTERING

J1448 Added Date:

October 1, 2021

J1448 Effective Date:

October 1, 2021

J1448 Termination Date:

HCPCS Active

Cosela billing and coding information can be found through G1 Therapeutics at the link below:
Cosela patient assistance information can be found through The G1 to One patient support program at the URL: https://www.cosela.com/patient/support
COSELA prescribing information can be found at the link below:
Information regarding COSELA’s side effects can be found at MedlinePlus